tiprankstipranks
CSPC Innovation Reports Declining Financial Performance
Company Announcements

CSPC Innovation Reports Declining Financial Performance

CSPC Pharmaceutical Group (HK:1093) has released an update.

Don't Miss Our Christmas Offers:

CSPC Innovation Pharmaceutical Co., a subsidiary of CSPC Pharmaceutical Group, reported a significant decline in its financial performance for the nine months ending September 2024. Revenue fell by 23.66% while net profit attributable to shareholders plummeted by 63.50% compared to the previous year. Investors are advised to exercise caution when dealing with the company’s securities amidst these challenging financial results.

For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskCSPC Pharmaceutical’s New siRNA Drug Gets Clinical Trial Nod
TipRanks HongKong Auto-Generated NewsdeskCSPC Pharmaceutical Gains Approval for Cancer Drug Trials
TipRanks HongKong Auto-Generated NewsdeskCSPC Pharmaceutical Gains Approval for Cancer Drug Trials
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App